TRACY MCKENZIE: Open Payments
NPI 1427897982 · MAITLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 30 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $241 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $93 |
| ABBVIE INC. | 3 | $60 |
| Merck Sharp & Dohme LLC | 3 | $50 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $43 |
| Boston Scientific Corporation | 2 | $40 |
| Novo Nordisk Inc | 2 | $38 |
| Abbott Laboratories | 2 | $37 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| GlaxoSmithKline, LLC. | 2 | $28 |
Products named: Kerendia, GARDASIL 9, NEFFY, FREESTYLE LIBRE 3, VRAYLAR, GEMTESA, TRELEGY ELLIPTA, INJECTAFER.
Industry payments across FL — which companies pay providers there.
